FDA Inspection 1068573 — Egilius L.H. Spierings, MD, PhD
The FDA completed an inspection of Egilius L.H. Spierings, MD, PhD on Sep 13, 2018 in Watertown, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 13, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Watertown, MA (United States)
Additional Details
Clinical Investigator (CI)